Skip to main content
Clinical Trials/ACTRN12616000721404
ACTRN12616000721404
Not yet recruiting
未知

Deprescribing anticholinergic and sedative medicines: A Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities

Professor Steve Duffull, Dean of the Pharmacy school0 sites150 target enrollmentJune 1, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Overprescription
Sponsor
Professor Steve Duffull, Dean of the Pharmacy school
Enrollment
150
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Professor Steve Duffull, Dean of the Pharmacy school

Eligibility Criteria

Inclusion Criteria

  • 1\.Aged 65 years or older
  • 2\.A drug burden index (DBI) of 0\.5 or greater
  • 3\.Taking at least one anticholinergic medication from the reference anticholinergic list published by Salahudeen et al. or one sedative medicine as listed by Hilmer et al.

Exclusion Criteria

  • 1\.Limited life expectancy: resident is receiving palliative care or their life expectancy is 3 months or less, based on Holmes life expectancy calculator
  • 2\.Residents admitted for hospice care (short\-duration of stay of less than 4 weeks)
  • 3\.Severe dementia: residents’ with a score on the Mini\-mental State Examination test (MMSE) \< 10
  • 4\.Resident’s not prescribed any anticholinergic medicines.

Outcomes

Primary Outcomes

Not specified

Similar Trials